Guangdong Hengrui Pharmaceutical Co: Clinical Trials & Research Profile

Biopharma Industry (Global / Institutional) · Primary Focus: Immunology, Rheumatology, and Dermatology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Global / Institutional)
Primary Therapeutic AreaImmunology, Rheumatology, and Dermatology
Active Phase II & III Studies24 active (15 recruiting now)
Total Tracked Studies (2018 to 2026)32
Completed vs Early-Stopped Studies7 completed / 1 stopped (3.1% stop rate)
Median Closed Enrollment103 participants
FDA Drugs@FDA Original Approvals0 all-time (0 from 2018 to 2026)
Physical Hospital Site Disclosure100.0% named hospital slots

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk